Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block(Renal Associates P. A.), William G. Goodman(Amgen (United States)), Ali K. Abu‐Alfa(Yale University), Gavril Hercz(University of Toronto), Kévin Martin(Bridge University), J. Braun(KfH Kuratorium für Dialyse und Nierentransplantation), Laura C. McCary(Amgen (United States)), Daniel W. Coyne(Washington University in St. Louis), Kurt Olson(Amgen (United States)), Raphael M. Cohen(Presbyterian Medical Center), Piergiorgio Messa(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesco Locatelli(University of Modena and Reggio Emilia), Michael Suranyi(Liverpool Hospital), Sharon M. Moe(Indiana University School of Medicine), Pieter Evenepoel(KU Leuven), John Cunningham(Centre for Addiction and Mental Health), Tilman B. Drüeke(Inserm), Albert Fournier(Centre Hospitalier Universitaire Amiens-Picardie), Ángel Francisco(Marqués de Valdecilla University Hospital), Stewart A. Turner(Amgen (United States)), Valter J. Zani(Amgen (United States)), Morrell M. Avram(Island Hospital)
Cited by 1,131
Related Papers
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
|Journal of the American Society of Nephrology|2004|2.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k